• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Rentrak Announces Official Worldwide Box Office Results for Weekend of September 14, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of September 14, 2014

  2. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    Top managers continue to focus on higher-quality dividend-paying stocks in a fully valued market.

  3. At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies

    At Four Years, Treatment Effect Maintained in More Than Two-Thirds of Patients Who Received Genzyme’s Lemtrada in Pivotal Studies

  4. EUROPE MARKETS: RBS, Lloyds Climb; Sanofi Slips: Europe's Big Stock Moves

    EUROPE MARKETS: RBS, Lloyds Climb; Sanofi Slips: Europe's Big Stock Moves

  5. RBS, Lloyds climb; Sanofi slips: Europe's big stock moves

    RBS, Lloyds climb; Sanofi slips: Europe's big stock moves

  6. Rentrak Announces Official Worldwide Box Office Results for Weekend of September 7, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of September 7, 2014

  7. FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

    FDA Approves Use of Menactra® Vaccine for Booster Immunization Against Potentially Deadly Disease

  8. Rentrak Announces Official Worldwide Box Office Results for Weekend of August 31, 2014

    Rentrak Announces Official Worldwide Box Office Results for Weekend of August 31, 2014

  9. Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

    Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014

  10. Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

    Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.